Effectiveness of Paricalcitol in Reducing Parathyroid Hormone Levels in X-linked Hypophosphatemic Rickets

Conditions

Hyperparathyroidism | Hypophosphatemia, Familial

What is the purpose of this trial?

The purpose of this study is to determine the effectiveness of paricalcitol, a form of synthetic vitamin D, in lowering parathyroid hormone (PTH) levels and reducing disease symptoms in children and adults with X-linked hypophosphatemic (XLH) rickets.



Participation Guidelines

Age:
9 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Yale University
Dates:
January 2007
Last Updated:
October 18, 2012
Study HIC#:
0607001636

Clinicaltrials.gov ID: NCT00417612